Bacterial vaginosis (BV) causes genital inflammation and increased
Bacterial vaginosis (BV) is a highly prevalent dysbiosis of the vaginal microbiota that is characterized by a shift from predominantly Lactobacillus species to a diverse population including pathogenic bacteria, such as Gardnerella vaginalis and Prevotella spp 1 . BV has been found to increase the risk of HIV acquisition in women, mother-to-child transmission and transmission from women with BV to their male partners, as well as reduce the efficacy of some forms of antiretroviral pre-exposure prophylaxis [2] [3] [4] [5] [6] . Additionally, BV is associated with increased susceptibility to other sexually transmitted infections (STIs) and severe reproductive complications in women 7, 8 . Although the underlying mechanisms are not fully understood, these outcomes may be partly mediated by increases in vaginal pro-inflammatory cytokine concentrations and immune cell activation in the female genital tracts (FGTs) of women with BV 9 . The relationship between BV and HIV is particularly concerning in South Africa, where approximately 18% of the adult population aged 15-49 years is HIV-infected 10 and BV prevalence rates are reported to exceed 50% in some regions Lactobacillus species, which dominate in a healthy FGT, are thought to protect against BV, HIV and other STIs by a number of mechanisms. Lactic acid produced by lactobacilli hinders the growth of potential pathogens and inactivates HIV 12, 13 , partly by maintaining the physiological pH of the vagina below 4.5 14 . Lactic acid exists as both D-and L-isomers; while L-lactic acid has been found to inactivate HIV more effectively than D-lactic acid 15 , D-lactic acid is thought to play a more important role in inhibiting bacterial pathogens, including Chlamydia trachomatis 16, 17 . Many lactobacilli also produce hydrogen peroxide (H 2 O 2 ), which has a virucidal effect on HIV by inhibiting viral adhesion and replication 18 . However, the role of H 2 O 2 in protection against BV-associated bacteria is controversial, as some studies have reported that physiological concentrations are not microbicidal and that, at microbicidal concentrations, H 2 O 2 inhibits lactobacilli more effectively than pathogenic bacteria 19 . Competitive exclusion is another important protective mechanism utilized by lactobacilli, whereby adherent lactobacilli prevent the adhesion of pathogens to the vaginal epithelium and thus colonization 20 . Genital inflammation caused by BV and STIs increases risk of HIV acquisition 21 . Suppression of inflammatory responses by lactobacilli and lactic acid is another proposed mechanism for reduced susceptibility to HIV in women with Lactobacillus-dominant microbiota 22 .
As the standard-of-care for BV, antibiotic treatment, is associated with high recurrence rates 14, 23 , there is an urgent need to develop better treatment strategies, particularly in regions of high HIV prevalence. Several randomized clinical trials have evaluated Lactobacillus-containing probiotics for BV treatment, alone or as adjunctive therapy with antibiotics 24, 25 . Although some trials have demonstrated improved BV outcomes with probiotics, the results have been heterogeneous, with some studies finding no benefit 24, 25 . One of the limitations of many of these probiotic formulations is that they include bacterial species that are not adapted for survival in the FGT and are not usually found in women with healthy vaginal microbiota 26 . It is also possible that probiotics containing Lactobacillus isolates from one population may have reduced efficacy when used in another population, as major geographical and ethnic differences have been observed in the vaginal microbiota and host factors that may influence bacterial colonization 27, 28 . Therefore, using vagina-specific Lactobacillus species with effective antimicrobial properties that have been isolated from within the population of intended use may improve BV treatment outcomes. The aims of this study were to compare the antimicrobial and inflammatory characteristics of existing vaginal probiotics on the South African market to those of clinical Lactobacillus isolates from the FGTs of South African women.
Results

Study population and Lactobacillus isolates.
Clinical Lactobacillus strains (n = 23) were isolated from cervicovaginal samples from nine women residing in Cape Town, South Africa (Table 1) 
29
. Of these, six women had no STIs or BV, two had BV and one was infected with Chlamydia trachomatis. All of the women were PCR negative for other STIs including: Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, herpes simplex virus (HSV)-1, HSV-2 and Treponema pallidum. The 23 clinical Lactobacillus isolates included seven L. crispatus Lactobacillus adhesion to genital epithelial cells. Lactobacillus isolates were tested for their ability to adhere to CaSki (ectocervical epithelial) cells (Fig. 1C-H) . Overall, the L. acidophilus probiotic isolate was the most adherent, although there was a large difference between the adhesion of the isolate obtained from the capsule (0.006%) versus the isolate obtained from the tablet (2.022%) (Fig. 1C,D) . Although there were no statistically significant differences in adhesion between species (Fig. 1C) , among the clinical isolates, L. jensenii 1 (LJ1) exhibited the greatest adhesion, with approximately 1.663% of bacteria adhering to the cells (Fig. 1D) . Several species included a relatively large proportion of highly adherent strains, with 1/2 (50%) L. acidophilus, 4/6 (67%) L. jensenii, and 1/2 (50%) L. gasseri relatively highly adherent. It has previously been suggested that bacterial size and growth rates may influence adhesion ability 30 . However, neither bacterial size nor growth rates correlated with Lactobacillus adhesion in this study (Spearman rho = 0.2209, p = 0.2407 and rho = 0.2843, p = 0.1278, respectively; data not shown).
Hydrogen peroxide production. L. mucosae isolates produced the most H 2 O 2 relative to the other strains collectively (p = 0.0044; adjusted p = 0.0308), after a 3 h incubation period under aerobic conditions, followed by L. jensenii isolates (p = 0.0061; adjusted p = 0.0427; data not shown). The other species evaluated produced comparably lower amounts of H 2 O 2 ( Fig. 2A) . Only one L. crispatus isolate, none of the L. vaginalis isolates and none of the probiotic Lactobacillus isolates produced significant amounts of H 2 O 2 (Fig. 2B) . The rates of H 2 O 2 production were similar for all producing isolates, with production being evident within 2 h (Fig. 2B) . The level of H 2 O 2 production was not associated with the growth rates of the lactobacilli (rho = −0.1136, p = 0.5501; data not shown).
D-and L-lactate production and culture acidification. When the lactobacilli were cultured in MRS, it was found that the probiotics lowered the culture pH levels most, followed by the L. crispatus isolates (Fig. 2C,D) . In contrast, L. vaginalis and L. mucosae culture pH levels were the highest. Most Lactobacillus isolates produced large amounts of D-lactate, with no significant differences between species after multiple comparisons adjustment (Fig. 2E,F) . L-lactate production was however highly varied between isolates (Fig. 2G,H) , with L. jensenii isolates producing significantly greater amounts of L-lactate than the other isolates collectively (p = 0.0013, adjusted p = 0.0091; data not shown), followed by L. gasseri and L. vaginalis (Fig. 2G) . While all the probiotic isolates produced large amounts of D-lactate, only the probiotic capsule L. acidophilus isolate produced detectable levels of L-lactate (Fig. 2F,H) .
The concentration of total lactic acid, calculated using the Henderson-Hasselbalch equation 31 , correlated with culture pH (rho = 0.8626, p < 0.0001; data not shown). Additionally, there was a trend towards a significant correlation between D-lactate and L-lactate production (Spearman rho = 0.3272, p = 0.0776; data not shown). Although there was a trend towards an inverse correlation between culture pH and bacterial growth rates (rho = −0.3079, p = 0.0978), neither D-lactate (rho = 0.07787, p = 0.6825) nor L-lactate (rho = 0.2520, p = 0.1791) correlated with growth rates (data not shown). were not produced (below the minimum levels of detection for all samples; not shown). The relative cytokine production elicited by each of the isolates is shown as a heatmap (Fig. 3A) . While most lactobacilli induced very little cytokine production by CaSki cells, some of the isolates were substantially more inflammatory than others, including two L. crispatus isolates, two L. jensenii isolates and the L. acidophilus vaginal tablet isolate which clustered separately from the other isolates assessed (Fig. 3A) . Factor analysis was used to group all of the inflammatory cytokines together onto one factor and generate overall inflammatory scores for each isolate (Fig. 3B,C) . L. acidophilus was most inflammatory, while L. gasseri isolates were the least inflammatory according to inflammatory factor scores (Fig. 3B ), although these differences were not statistically significant. Of the individual isolates assessed, LJ1 was the most inflammatory, while LG1 was the least inflammatory (Fig. 3C) .
Inflammatory cytokine responses.
To evaluate the impact of D-and L-lactate concentrations on inflammatory responses, these metabolites were measured in lactobacilli-CaSki co-cultures following a 24 hour incubation at 37 °C under aerobic conditions (Fig. 4) . It was found that neither D-lactate nor L-lactate correlated significantly with inflammatory cytokine production by CaSki cells (data not shown).
To validate these findings using an alternative experimental approach, cytokine responses to isolates adjusted to optical densities at a wavelength of 600 nm (OD 600 ) of 0.1 ± 0.01 were evaluated. It was found that the cytokine factor scores between assays (OD-adjusted bacteria versus 4.18 × 10 6 CFU of bacteria used for stimulation) were Percentage adhesion (%) overall probiotic-relevant performance of isolates. A scoring system was devised to compare and rank the isolates based on all of the characteristics investigated. Each isolate was given scores out of a maximum score of three per characteristic, according to (1) growth rates; (2) culture pH acidification; the levels of (3) H 2 O 2 , (4) L-and (5) D-lactate produced, (6) ability to adhere to epithelial cells and (7) induction of inflammatory responses by CaSki cells ( 
Discussion
BV, an imbalance in vaginal microbiota that predisposes women to HIV infection and reproductive complications, remains prevalent, in part because standard-of-care antibiotic therapy is largely ineffective 14, 32 . Adjunctive probiotic treatment for BV may promote vaginal recolonization with healthy lactobacilli, however BV treatment outcomes have been heterogeneous in probiotic clinical trials. Here, we show that the performance of the only vaginal probiotics available on the South African market were highly varied based on the criteria evaluated in this study, providing a possible explanation for the heterogeneous efficacy of probiotic treatment in BV. Neither L. acidophilus nor L. casei rhamnosus species predominate in the FGTs of women with healthy microbiota 27 and were not isolated from the cohort of women included in this study, suggesting that these species might not be ideal for treatment of BV in South African women. In this study, we evaluated Lactobacillus species that have been associated with vaginal health, including L. crispatus, L. gasseri, L. jensenii, L. mucosae and L. vaginalis. L. iners was not included as this species is associated with increased risk of conversion from a healthy to a dysbiotic Mann-Whitney test was used for comparisons between species and p-values < 0.05 after adjustment for multiple comparisons were considered statistically significant. LA: Lactobacillus acidophilus probiotic (n = 2); LC: Lactobacillus crispatus (n = 9); LCR: Lactobacillus casei rhamnosus probiotic (n = 1); LG: Lactobacillus gasseri (n = 2); LM: Lactobacillus mucosae (n = 4); LV: Lactobacillus vaginalis (n = 6); LJ: Lactobacillus jensenii (n = 6). *ATCC reference strains. vaginal microbiome 33 , and acquisition of STIs 34 . We found that several of the clinical isolates performed better than the probiotic strains, demonstrating the potential to improve existing probiotic formulations and treatment outcomes using novel clinical isolates. We also found that, although some Lactobacillus isolates induced inflammatory responses when cultured with ectocervical epithelial cells in isolation, when we pre-incubated the cells with a subset of six isolates prior to addition of G. vaginalis, 5/6 of the lactobacilli significantly reduced pro-inflammatory cytokine responses to G. vaginalis.
Several antimicrobial and other characteristics that are thought to be important for effective probiotic activity were evaluated for each Lactobacillus isolate 16, 18, 20 . Adhesion, thought to be mediated by specialized pili 35 , is an essential probiotic property as it enables the bacteria to persist in the FGT 36 . In this study, there were no significant differences in the level of adhesion between species. Larger bacterial size has been linked to superior adhesion capabilities 30 , however the relative length of bacteria in this study did not correlate significantly with adhesion. Moreover, although it has been reported that rapid bacterial multiplication leads to a high adhesion capacity 30 , in the present study, bacterial growth rates were not significantly associated with adhesion. 19, 39 . It is important to note that, using an in vitro model to evaluate the characteristics of Lactobacillus isolates has limitations as this environment does not perfectly mimic in vivo conditions.
In contrast, lactic acid at physiological concentrations was shown to be microbicidal against pathogenic BV-associated bacteria (including G. vaginalis, P. bivia and P. corporis), but not vaginal lactobacilli 16, 17, 19, 39 . Physiological concentrations of lactic acid have also been shown to have broad-spectrum virucidal activity against HIV that is dramatically more rapid and potent than media acidified to the same pH with HCl or acetic acid 15, 40 . Interestingly, all isolates in this study produced D-lactate with no significant differences between species. However, L-lactate production was highly varied, with L. jensenii isolates producing the most L-lactate in both MRS under anaerobic conditions and in DMEM under aerobic conditions overall. The relative importance of L-lactic acid versus D-lactic acid is also controversial. L-lactic acid was found to be 17-fold more potent than D-lactic acid in inactivating HIV BaL in vitro 15, 40 . However, D-lactic acid was found to have a greater inhibitory effect on C. trachomatis infectivity than L-lactic acid, which was partly 41 or entirely 39 pH-dependant. Similar to the finding that lactic acid concentrations correlate inversely with pH in the FGTs of women with Lactobacillus-dominated microbiota 31 , we found that lactic acid concentrations correlated significantly with culture pH. As found in the present study, a previous study showed that the vaginal acidity achieved by L. crispatus was the highest compared to L. jensenii and L. gasseri 27 . Interestingly, in the present study, the L. casei rhamnosus probiotic isolate was associated with the lowest culture pH, followed by L. acidophilus probiotic.
We measured inflammatory responses to lactobacilli, as genital inflammation has been found to increase risk of HIV acquisition in women 21 and it is thus essential that probiotics induce little or no inflammation. Most of the isolates in isolation induced low levels of cytokine production by CaSki cells following a 24 h incubation period. However we also found that most of the lactobacilli evaluated were able to significantly suppress inflammatory cytokine production by CaSki cells in response to the BV-associated pathogen, G. vaginalis. In vivo, in the same cohort from whom the lactobacilli were isolated, we found that endogenous L. reuteri, L. gasseri, L. crispatus and L. jensenii were all significantly associated with low inflammation in the FGT 42 . Other studies have reported that lactobacilli and lactic acid suppress inflammatory responses to pathogens and pattern recognition receptor ligands in vitro 22, 26 . It is interesting that, in this study, some of the lactobacilli in isolation were able to induce increases in pro-inflammatory cytokine production and 1/6 of the lactobacilli included in the G. vaginalis co-culture experiment had an additive effect on cytokine induction. Additionally, anti-inflammatory IL-10 production was not detected in these cultures and IL-1RA production was suppressed by lactobacilli. Another study showed that, while L. rhamnosus and L. reuteri suppressed the expression of certain inflammatory mediators by vaginal epithelial cells in response to Candida albicans [including nuclear factor-kappa B inhibitor kinase alpha, toll-like receptor (TLR)-2, TLR-6, IL-8, and TNF-α], the lactobacilli also induced expression of pro-inflammatory cytokines IL-1α and IL-1β 43 . The authors suggested that the lactobacilli may suppress inflammatory responses induced by the NF-κB signal transduction pathway, but induce other inflammatory responses via an alternate signal pathway, such as the mitogen activated protein kinase and activator protein-1 (MAPK/AP-1) signal transduction pathway 43 . Similarly Rose et al. (2012) found that lactobacilli induced non-significant increases in the production of some inflammatory cytokines by vaginal epithelial cells cultured in transwell culture systems 44 . Proteins present in the peptidoglycan layer of the Lactobacillus cell wall and lipoteichoic acids present in the cell membrane may have inflammatory properties and the inflammatory nature of particular Lactobacillus strains has been found to be partly dependent on the structure of the peptidoglycan and the presence of exopolysaccharides which prevent the interaction of these TLR agonists with pattern recognition receptors 45 . Therefore it is not surprising that some isolates are capable of inducing inflammatory responses. Lactic acid itself was found to have direct pro-inflammatory effects on immune and vaginal epithelial cells in some studies 46, 47 , but anti-inflammatory effects in others 22 . In this study, we found that neither D-lactate nor L-lactate production correlated with cytokine LA: Lactobacillus acidophilus probiotic (n = 2); LC: Lactobacillus crispatus (n = 9); LCR: Lactobacillus casei rhamnosus probiotic (n = 1); LG: Lactobacillus gasseri (n = 2); LM: Lactobacillus mucosae (n = 4); LV: Lactobacillus vaginalis (n = 6); LJ: Lactobacillus jensenii (n = 6). *ATCC reference strains. production by CaSki cells in response to the lactobacilli isolates. In addition to influencing inflammatory pathways directly, lactobacilli may alter inflammatory responses to pathogens by means of competitive exclusion, preventing pathogens from interacting with vaginal epithelial cells 20, 30 . Interestingly, although the lactic acid concentrations measured in these cultures were lower than those present in FGT secretions 31 , we still observed suppression of pro-inflammatory responses to G. vaginalis and inhibition of G. vaginalis growth by Lactobacillus isolates and culture supernatants, respectively. Inflammatory cytokine induction by some of the lactobacilli demonstrates the need to evaluate inflammatory profiles of bacterial isolates being considered for vaginal probiotic therapy. A limitation of this study is that an ectocervical cancer cell line was used to evaluate lactobacilli adhesion and inflammatory properties to allow for high-throughput screening. However, the inflammatory properties of these cells may differ from healthy cells and it will thus be important to confirm that probiotic candidates do not induce inflammatory responses using other models. Interestingly, the characteristics of the Lactobacillus isolates from South African women investigated in this study differed in some respects to the characteristics of isolates from other geographical regions and women of different ethnicities 27, 28 . While studies in other regions, including America and Spain 37, 48 , have found that L. crispatus strains produce high levels of H 2 O 2 and lactic acid, this study found that these South African L. crispatus isolates generally produced relatively little of these antimicrobials. Similarly, major geographical and ethnic differences in the vaginal microbiome have been noted. African women were found to have a low abundance of Lactobacillus that was not associated with sexual behavior, contraceptive usage, or demographic characteristics 4 . A lower frequency of L. crispatus and L. jensenii has been observed in black and Hispanic women compared to white and Asian women in the United States, suggesting that host genetic or dietary factors may play a role in bacterial colonization of the FGT 5,27,49 . However it is also possible that the characteristics of the predominant Lactobacillus strains present in certain populations influence the species distribution.
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According to the characteristics that were assessed in this study that may influence Lactobacillus antimicrobial activity (including growth rates, culture pH, adhesion, H 2 O 2 , lactic acid and inflammatory responses), several South African clinical isolates performed better than the commercial probiotic Lactobacillus isolates evaluated. Of the top ten Lactobacillus isolates, L. jensenii and L. crispatus were well represented, while L. mucosae and L. vaginalis strains were mostly absent. Five clinical isolates performed better than the probiotic L. acidophilus strain, suggesting that there is indeed potential to improve existing probiotics that may, in turn, improve BV treatment outcomes. Bacterial isolation and culture. Cervicovaginal fluid was collected in menstrual cups (Softcup ® , Evofem Inc, USA), diluted in phosphate buffered saline (PBS) and frozen in 20% glycerol at −80 °C. Cervicovaginal fluid was thawed and cultured in sterile de Man, Rogosa, Sharpe (MRS) broth anaerobically for 48 h at 37 °C, streaked on MRS-agar and incubated anaerobically at 37 °C for 48 h. Morphologically distinct single colonies were picked and inoculated in MRS broth and incubated anaerobically at 37 °C for 72 h. Bacterial isolates (n = 50) were cultured from 20 participants and identified using MALDI biotyping (Bruker Daltonik, USA). From these, 23 isolates from 9 women were identified as Lactobacillus species and were included. Microscopy was used to measure the length of 5 bacteria per isolate (Leica ICC50 HD, Leica Microsystems, Germany). Growth rates were evaluated by inoculating MRS broth with 4.18 × 10 6 CFU 47 of each isolate in triplicate and measuring the OD 600 of cultures over time. The area under the curve (AUC) was calculated for each isolate between 0 and 12 h, after which stationary phase was reached.
Methods
Bacterial adhesion to genital epithelial cells. The ability of the lactobacilli to adhere to human ectocervical epithelial cells, CaSki (CRL-1550, ATCC, USA), was evaluated as described previously 50 . CaSki cells were grown to 80% confluency in complete cell culture medium [Dulbecco's Modified Eagle's Medium (DMEM) with L-Glutamine (Lonza, Switzerland), 10% fetal calf serum (Capricorn-Scientific, Germany) and 1% penicillin (50U/ml) and streptomycin (50U/ml; Sigma-Aldrich, USA)] in 24 well plates and then washed with PBS. Bacteria adjusted to OD 600 of 0.1 ± 0.01 in antibiotic-free cell culture medium were added and incubated for 2 h at 37 °CC, 5% CO 2 . Culture medium was removed and plates were washed 3 times with PBS to remove unbound bacteria. 0.1% TritonX-100 (Sigma-Aldrich, USA) was added and the monolayers were lifted with cell scrapers. Serial dilutions were plated on MRS agar and colonies were counted following anaerobic incubation at 37 °C for 48 h. CFU/ml was calculated and expressed as a percentage of the baseline CFU/ml added to each monolayer. This experiment was repeated three times. For visual confirmation of bacterial adhesion to CaSki cells, bacteria were added to cell monolayers in Nunc TM Lab-Tek TM II Chamber Slides (Thermo Fisher Scientific Inc., USA) and incubated for 2 h at 37 °C, 5% CO 2 . Cell culture medium was removed and wells were washed 3 times with PBS. Chambers were removed before each slide was heat-fixed and Gram-stained. Representative images were captured (Leica ICC50 HD, Leica Microsystems, Germany). 7 CFU) was then added to each well and cultures were incubated for a further 20 hours. Supernatants were collected and processed as above and a Magnetic Luminex Screening Assay kit (R&D Systems, Minneapolis, USA) was then used to measure IL-1α, IL-6, IL-8, IP-10 and IL-1RA concentrations. Data was collected using a Bio-Plex TM Suspension Array Reader and a 5 parameter logistic regression was used to calculate cytokine concentrations from the standard curves using BIO-plex manager software (version 4; Bio-Rad Laboratories Inc ® , USA). Cytokine concentrations below the detectable limit were assigned the value of half the lowest recorded concentration of that cytokine.
D-and L-lactic acid production. Following a 24 h incubation period at 37 °C under anaerobic conditions, 4.18 × 10 6 CFU of each isolate was added to 15 ml MRS broth and incubated for an additional 24 h at 37 °C under anaerobic conditions. Supernatants were collected and D-and L-lactate concentrations were measured in duplicate using D-Lactate Colorimetric and Lactate Assay kits according to the manufacturer's instructions (Sigma-Aldrich, USA). Both D-and L-lactate concentrations were also measured in lactobacilli-CaSki cell co-cultures following aerobic incubation at 37 °C for 24 h under 5% CO 2 using D-Lactate Colorimetric and Lactate Assay kits according to the manufacturer's instructions (Sigma-Aldrich, USA) . 6 CFU/ml in MRS and incubated for an additional 20 h at 37 °C under anaerobic conditions, after which they were filtered using 0.2 μm cellulose acetate filters (Sigma-Aldrich, USA). Following 48 h incubation in brain heart infusion (BHI) broth at 37 °C under anaerobic conditions, G. vaginalis was standardized to 1 × 10 8 CFU/ml and cultured with each lactobacilli cell-free supernatant anaerobically for 24 h at 37 °C. Absorbance at OD 600 was measured at baseline and 24 h after incubation. Following the 24 h incubation, G. vaginalis cultures were plated on BHI agar and incubated for 24 h at 37 °C under anaerobic conditions, after which CFUs were counted 12 .
G. vaginalis inhibition assay. Six
Effect of hydrogen peroxide and bacteriocins on G. vaginalis inhibition. Three Lactobacillus isolates (LJ2, LM2 and LG1), that were found to inhibit G. vaginalis growth, were standardized to 4.18 × 10 6 CFU/ ml and cultured in MRS broth for 20 h at 37 °C under anaerobic conditions. To abrogate the possible effect of H 2 O 2 and bacteriocins, lactobacilli cell-free supernatants and MRS were pre-treated for 1 h at 37 °C with catalase (100 µg/ml) or proteolytic enzymes [trypsin (200 µg/ml), pepsin (200 µg/ml), pronase (200 µg/ml) and proteinase K (100 µg/ml)]. Pre-treated lactobacilli cell-free supernatants, pre-treated MRS and untreated MRS were then added 1 × 10 8 CFU/ml of G. vaginalis. Absorbance at OD 600 was measured at baseline, 24 and 48 h after incubation at 37 °C under anaerobic conditions 12 
.
Statistical Analysis. GraphPad Prism 5 ® (GraphPad Software, USA), STATA version 11.0 (StataCorp, USA), and R were used for statistical analyses. Mann Whitney U and Student's t-tests were used for unpaired comparisons of non-parametric and parametric data, respectively; Spearman Rank test was used for non-parametric correlations. A false-discovery rate (FDR) step-down procedure was used to adjust p-values for multiple comparisons and adjusted p-values < 0.05 were considered statistically significant. Unsupervised hierarchical clustering was used to evaluate the relationship between lactobacilli and cytokine profiles. To compare overall inflammatory cytokine responses, confirmatory factor analysis was used to generate inflammatory factor scores, which are linear combinations of the concentrations of each inflammatory cytokine (IL-1α, IL-1β, IL-6, IL-8, IP-10, MIP-1α, MIP-1β, MIP-3α, RANTES) in the factor, weighted according to their factor loadings.
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